• Home
  • Search Results
  • Changing the peptide specificity of a human T-cell receptor by directed evolution.

Changing the peptide specificity of a human T-cell receptor by directed evolution.

Nature communications (2014-11-08)
Sheena N Smith, Yuhang Wang, Javier L Baylon, Nishant K Singh, Brian M Baker, Emad Tajkhorshid, David M Kranz
ABSTRACT

Binding of a T-cell receptor (TCR) to a peptide/major histocompatibility complex is the key interaction involved in antigen specificity of T cells. The recognition involves up to six complementarity determining regions (CDR) of the TCR. Efforts to examine the structural basis of these interactions and to exploit them in adoptive T-cell therapies has required the isolation of specific T-cell clones and their clonotypic TCRs. Here we describe a strategy using in vitro-directed evolution of a single TCR to change its peptide specificity, thereby avoiding the need to isolate T-cell clones. The human TCR A6, which recognizes the viral peptide Tax/HLA-A2, was converted to TCR variants that recognized the cancer peptide MART1/HLA-A2. Mutational studies and molecular dynamics simulations identified CDR residues that were predicted to be important in the specificity switch. Thus, in vitro engineering strategies alone can be used to discover TCRs with desired specificities.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Propionic acid, ACS reagent, ≥99.5%
Sigma-Aldrich
Propionic acid, ≥99.5%
Supelco
Propionic acid, analytical standard
Sigma-Aldrich
Propionic acid, ≥99.5%, FCC, FG
Sigma-Aldrich
Propionic acid, natural, 99%, FG
Sigma-Aldrich
Propionic acid, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Propionic acid, BioReagent, suitable for insect cell culture, ~99%